Results 81 to 90 of about 12,843 (160)

Postexposure Treatment of Marburg Virus Infection

Emerging Infectious Diseases, 2010
Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus–based vaccine is administered 20–30 min after infection with Marburg virus.
Thomas W. Geisbert, Lisa E. Hensley, Joan B. Geisbert, Anders Leung, Joshua C. Johnson, Allen Grolla, Heinz Feldmann   +6 more
doaj   +1 more source

Evaluation of long-term immunity following inoculation with highly diverse orthomarburgvirus isolates in Egyptian rousette bats (Rousettus aegyptiacus)

Journal of Virology
Viral coinfections and their impact on long-term immunity represent an understudied area in disease ecology and infectious disease research. Coinfections can influence the host’s susceptibility to future infections, alter host and pathogen population ...
Jessica A. Elbert, Amy J. Schuh, Brian R. Amman, Jonathan C. Guito, James C. Graziano, Tara K. Sealy, Elizabeth W. Howerth, Jonathan S. Towner   +7 more
doaj   +1 more source

Transcriptomics of Marburg virus-infected primary proximal tubular cells reveals negative correlation of immune response and energy metabolism

Virus Research
Marburg virus, a member of the Filoviridae, is the causative agent of Marburg virus disease (MVD), a hemorrhagic fever with a case fatality rate of up to 90 %.
Benjamin Koch, Maximilian Filzmayer, Sammy Patyna, Nils Wetzstein, Sebastian Lampe, Tobias Schmid, Helmut Geiger, Patrick C. Baer, Olga Dolnik   +8 more
doaj   +1 more source

Marburg virus disease: a comprehensive review

Clinical Microbiology Reviews
SUMMARY Marburg virus disease (MVD) is a highly fatal illness closely resembling Ebola disease, caused by either Marburg virus (MARV) or Ravn virus (RAVV). It typically begins with a sudden onset of high fever, headache, and malaise, followed by severe gastrointestinal symptoms, bleeding disorders, and, in the most severe cases, multi-
Courtney Woolsey, Thomas W. Geisbert
openaire   +2 more sources

Serologic evidence of orthomarburgviruses and an orthoebolavirus in frugivorous Malagasy bats

One Health Outlook
Recent outbreaks of Marburg virus disease in regions of sub-Saharan Africa without prior record such as Ghana, Tanzania, Equatorial Guinea, and Rwanda challenge the current understanding of areas at-risk for filovirus spillover.
Marana S. Rekedal, Emily Cornelius Ruhs, Hafaliana Christian Ranaivoson, Neil Mittal, Spencer L. Sterling, Gwenddolen Kettenburg, Angelo Andrianiaina, Santino Andry, Lianying Yan, Axel T. Lehrer, Jean-Michel Héraud, Vincent Lacoste, Philippe Dussart, Cara E. Brook, Eric D. Laing   +14 more
doaj   +1 more source

Marburg Virus Disease: Global Threat or Isolated Events? [PDF]

J Infect Dis, 2023
Marzi A, Feldmann H.
europepmc   +1 more source

Marburg Virus Disease [PDF]

, 2020
openaire   +1 more source

Strategies for Managing Marburg Virus Disease Outbreaks: Lessons from the Rwanda Outbreak. [PDF]

Infect Drug Resist
Muvunyi CM, Iradukunda PG, Gashema P, Azhary A, Taha Osman Ali E, Siddig EE, Harelimana JD.   +6 more
europepmc   +1 more source

Marburg virus disease outbreak in Tanzania: current efforts and recommendations - a short communication. [PDF]

Ann Med Surg (Lond), 2023
Bulimbe DB, Masunga DS, Paul IK, Kassim GH, Bahati PB, Thomas JA, Mwakisole C, Nazir A, Uwishema O.   +8 more
europepmc   +1 more source

Emergence of Marburg virus disease in Ethiopia: Implications for public health preparedness and its impact on Ethiopia's health system. [PDF]

PLoS Negl Trop Dis
Biadgilign S, Fransua M, Eshetu A, Bedru A.   +3 more
europepmc   +1 more source